Customised therapeutic solutions

INC Research^®; provides therapeutically focused drug development services to customers around the globe. As a specialist contract research organisation (CRO), the company manages programmes for pharmaceutical and biotech companies developing drugs in the complex areas of neurology, psychiatry, and pain and cancer research. It also offers specialist paediatric drug development expertise across all therapeutic areas.

• Therapeutic expertise: The INC Research team consists of the brightest people in the industry, with years of central nervous system (CNS), oncology and industry-related experience, from its top scientists to its data entry group.
• Customised service: A customer-centric focus is a clear, common objective across the entire organisation. The company tailors its full range of services, processes and technology to the unique needs of each client and their specific project requirements. The high percentage of repeat business is a testament to the quality and dedication of the INC Research team.
• Global presence: With a presence in 32 countries worldwide, the company can deploy its services anywhere, on any scale.

INC CNS

INC Research is recognised as a leader in the field of CNS research. Over the last 20 years it has built up a reputation as a leading CNS expert by staying true to its therapeutic focus and conducting trials in pain, neurology and psychiatry. It continues to build and enhance its team of expert CNS professionals and the services they provide. The strength of the team’s first-hand knowledge in these areas has a direct impact on its customers’ critical CNS drug development programme.

As a niche provider, INC CNS^®; has conducted over 200 global CNS trials involving over 45,000 patients at 3400+ sites in 26 countries.

INC Oncology

Cancer is not one disease, but an entire category of diseases, and as many fields of research exist as there are types of cancer. INC Oncology^®; has the experience and resources to help clients with any facet of research. Its dedicated oncology team offers comprehensive clinical expertise, from early stage planning, study design and management through all phases of cancer trials. In addition to its clinical experience, INC Oncology has provided regulatory planning and consulting, statistical analysis advice and medical writing support on numerous oncology programmes.

Oncology is the team’s passion, not its job. It has the right culture to take on complex cancer trials; such trials are long, difficult and risky, but it has proven equal to the task, mobilising global, multidisciplinary teams to develop and implement 40 oncology trials over the last two years. These trials, of varying phase and size, have evaluated a variety of therapies (using numerous critical endpoints), preventive measures and patient care considerations for a broad spectrum of cancer indications.

INC DataSpectrum

INC Research’s data services division offers clients innovative data management solutions. It provides a full range of data management, statistical analysis and medical writing services to meet customers’ global drug development needs. Its ‘no-barriers’ approach integrates all data capture methods – EDC, fax and paper – into one validated system, built on Oracle Clinical™. This allows clients to choose the data capture method or methods best suited to each site and each study.

INC Pediatrics

INC Pediatrics ™ is a division dedicated to helping customers develop the best possible clinical trials for neonates, infants, children and adolescents. Led by authorities in paediatric research, the team has extensive paediatric study expertise, as well as experience in dealing with children in the clinical setting. The division understands the nuances of assent and informed consent, and has experience in providing regulatory and medical consultation in European paediatric trials.

INC Pediatrics manages paediatric clinical trials from start to finish – from protocol design to delivering the paediatric data required by regulatory agencies. With its support numerous clients have met the demands of FDA written requests in the pursuit of marketing exclusivity.

For further information, visit www.incresearch.com.